ClinicalTrials.gg
Sign In

Pulpitis clinical trials

The registry lists 316 studies for Pulpitis across more than 10 countries. 90 are recruiting or about to start. 280 of them are mainly about Pulpitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Pulpitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
152
Status unknown
51
Not yet recruiting
49
Recruiting
41
Active, not recruiting
16
Withdrawn
4

Phase

Phase 4
29
Phase 2
24
Phase 3
16
Early Phase 1
8
Phase 1
7

Where

Egypt
73
India
36
Turkey
33
Pakistan
28
Jordan
9
United States
9

Who runs them

Cairo University (59) · Postgraduate Institute of Dental Sciences Rohtak (25) · Ain Shams University (12) · Jamia Millia Islamia (10) · Suez Canal University (6) · Minia University (5) · Jordan University of Science and Technology (5) · Al-Azhar University (4)

What is being tested here

Drugs under test in Pulpitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone313
Epinephrine103
Diclofenac133
Dexamethasone phosphate111
Buffered Lidocaine101
Prednisolone012
Mineral trioxide aggregate002
Carticaine002
Lidocaine002
Tricalcium silicate001

Drug classes tested here Corticosteroids 3 open · NSAIDs 1 open · Local anesthetics 5

Coming up

1phase 3 study under way
35studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 41 Pulpitis studies recruiting now, 9 (22%) set no upper age limit and 32 (78%) stop at 75 or younger. 19 (46%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 24 (59%) take healthy volunteers.

Recruiting studies that take each age, of 41
AgeWomenMen
104 (10%)4 (10%)
1832 (78%)31 (76%)
3033 (80%)32 (78%)
4029 (71%)28 (68%)
5020 (49%)20 (49%)
6510 (24%)10 (24%)
759 (22%)9 (22%)
859 (22%)9 (22%)

Across all 316 studies, recruiting or not: 81% stop at 75 or younger and 78% at 65; 36% take children; 1% are for women only and 1% for men only; 59% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pulpitis studies take

Of 15 phase 4 interventional studies under Pulpitis, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 48 mo5–13 · 15 studies——
Interventional, no phase16 mo9–28 · 158 studies—16 mo9–28 · 158 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 316. Browse all 316 → or search them.